Injectable weight-loss medicines referred to as semaglutides are serving to folks with weight problems by decreasing urge for food. But might these medicine even be the subsequent breakthrough in conserving your coronary heart wholesome?
The Food and Drug Administration (FDA) not too long ago permitted Wegovy, a model identify of semaglutide, as a secondary prevention treatment to cut back threat of significant coronary heart issues.
____________________________________________
FOR THE PUBLIC: More well being and medical information on the Mayo Clinic News Network. https://newsnetwork.mayoclinic.org/
FOR THE MEDIA ONLY: To entry clear and NAT sound variations of this video on the Mayo Clinic News Network, register at https://newsnetwork.mayoclinic.org/request-account/
Mayo Clinic: https://mayocl.in/3tNMAdF
Like Mayo Clinic on Facebook: https://www.facebook.com/MayoClinic
Follow Mayo Clinic on Instagram https://www.instagram.com/mayoclinic/
Follow Mayo Clinic on X, previously Twitter: https://x.com/MayoClinic
Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
